inhibition of inflammation

Acute lung injury is a therapeutically high unmet need indication caused by uncontrolled inflammation with high expression of mediators to promote inflammation, called cytokines. If not reversed, it leads to acute respiratory distress syndrome (ARDS) as major reason for death in patients with COVID-19. Nekonal validated specific acting compounds and biomarkers to detect and stopp uncontrolled hyperimmune activation at early stage.